Skip to main content
Top
Published in: BMC Pregnancy and Childbirth 1/2021

Open Access 01-12-2021 | Thrombocytopenia | Research article

Mild thrombocytopenia indicating maternal organ damage in pre‐eclampsia: a cross‐sectional study

Authors: Michinori Mayama, Mamoru Morikawa, Takashi Yamada, Takeshi Umazume, Kiwamu Noshiro, Kinuko Nakagawa, Yoshihiro Saito, Kentaro Chiba, Satoshi Kawaguchi, Hidemichi Watari

Published in: BMC Pregnancy and Childbirth | Issue 1/2021

Login to get access

Abstract

Background

Currently, there is a disagreement between guidelines regarding platelet count cut-off values as a sign of maternal organ damage in pre-eclampsia; the American College of Obstetricians and Gynecologists guidelines state a cut-off value of < 100 × 109/L; however, the International Society for the Study of Hypertension in Pregnancy guidelines specify a cut-off of < 150 × 109/L. We evaluated the effect of mild thrombocytopenia: platelet count < 150 × 109/L and ≥ 100 × 109/L on clinical features of pre-eclampsia to examine whether mild thrombocytopenia reflects maternal organ damage in pre-eclampsia.

Methods

A total of 264 women were enrolled in this study. Participants were divided into three groups based on platelet count levels at delivery: normal, ≥ 150 × 109/L; mild thrombocytopenia, < 150 × 109/L and ≥ 100 × 109/L; and severe thrombocytopenia, < 100 × 109/L. Risk of severe hypertension, utero-placental dysfunction, maternal organ damage, preterm delivery, and neonatal intensive care unit admission were analyzed based on platelet count levels. Estimated relative risk was calculated with a Poisson regression analysis with a robust error.

Results

Platelet counts indicated normal levels in 189 patients, mild thrombocytopenia in 51 patients, and severe thrombocytopenia in 24 patients. The estimated relative risks of severe thrombocytopenia were 4.46 [95 % confidence interval, 2.59–7.68] for maternal organ damage except for thrombocytopenia, 1.61 [1.06–2.45] for preterm delivery < 34 gestational weeks, and 1.35 [1.06–1.73] for neonatal intensive care unit admission. On the other hand, the estimated relative risks of mild thrombocytopenia were 0.97 [0.41–2.26] for maternal organ damage except for thrombocytopenia, 0.91 [0.62–1.35] for preterm delivery < 34 gestational weeks, and 0.97 [0.76–1.24] for neonatal intensive care unit admission.

Conclusions

Mild thrombocytopenia was not associated with severe features of pre-eclampsia and would not be suitable as a sign of maternal organ damage.
Literature
1.
go back to reference American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122–31.CrossRef American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122–31.CrossRef
2.
go back to reference Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. Hypertension. 2018;72:24–43.CrossRef Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. Hypertension. 2018;72:24–43.CrossRef
4.
go back to reference Thalor N, Singh K, Pujani M, Chauhan V, Agarwal C, Ahuja R. A correlation between platelet indices and pre-eclampsia. Hematol Transfus Cell Ther. 2019;41:129–33.CrossRef Thalor N, Singh K, Pujani M, Chauhan V, Agarwal C, Ahuja R. A correlation between platelet indices and pre-eclampsia. Hematol Transfus Cell Ther. 2019;41:129–33.CrossRef
5.
go back to reference Cines DB, Levine LD. Thrombocytopenia in pregnancy. Blood. 2017;130:2271–7.CrossRef Cines DB, Levine LD. Thrombocytopenia in pregnancy. Blood. 2017;130:2271–7.CrossRef
6.
go back to reference Mayama M, Morikawa M, Umazume T, Nakagawa K, Hosokawa A, Yamaguchi M, et al. Increase in the number of patients diagnosed using the new classification of hypertensive disorders of pregnancy in Japan. J Obstet Gynaecol Res. 2019;45:1118–26.CrossRef Mayama M, Morikawa M, Umazume T, Nakagawa K, Hosokawa A, Yamaguchi M, et al. Increase in the number of patients diagnosed using the new classification of hypertensive disorders of pregnancy in Japan. J Obstet Gynaecol Res. 2019;45:1118–26.CrossRef
7.
go back to reference McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies ad clinical trials of common outcomes. Am J Epidemiol. 2003;157:940–3.CrossRef McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies ad clinical trials of common outcomes. Am J Epidemiol. 2003;157:940–3.CrossRef
8.
go back to reference Khodzhaeva ZS, Kogan YA, Shmakov RG, Klimenchenko NI, Akatyeva AS, Vavina OV. et al. Clinical and pathogenetic features of early- and late-onset pre-eclampsia. J Matern Fetal Neonatal Med. 2016;29:2980-6.CrossRef Khodzhaeva ZS, Kogan YA, Shmakov RG, Klimenchenko NI, Akatyeva AS, Vavina OV. et al. Clinical and pathogenetic features of early- and late-onset pre-eclampsia. J Matern Fetal Neonatal Med. 2016;29:2980-6.CrossRef
9.
go back to reference Practice bulletin no. 166: thrombocytopenia in pregnancy. Obstet Gynecol. 2016;128:e43–53.CrossRef Practice bulletin no. 166: thrombocytopenia in pregnancy. Obstet Gynecol. 2016;128:e43–53.CrossRef
10.
go back to reference Burrows RF, Kelton JG. Thrombocytopenia at delivery: A prospective survey of 6715 deliveries. Am J Obstet Gynecol. 1990;162:731–4.CrossRef Burrows RF, Kelton JG. Thrombocytopenia at delivery: A prospective survey of 6715 deliveries. Am J Obstet Gynecol. 1990;162:731–4.CrossRef
11.
go back to reference Gernsheimer T, James AH, Stasi R. How I treat thrombocytopenia in pregnancy. Blood. 2013;121:38–47.CrossRef Gernsheimer T, James AH, Stasi R. How I treat thrombocytopenia in pregnancy. Blood. 2013;121:38–47.CrossRef
12.
go back to reference Freitas LG, Alpoim PN, Komatsuzaki F, Carvalho Md, Dusse LM. Pre-eclampsia: are platelet count and indices useful for its prognostic? Hematology. 2013;18:360–4.CrossRef Freitas LG, Alpoim PN, Komatsuzaki F, Carvalho Md, Dusse LM. Pre-eclampsia: are platelet count and indices useful for its prognostic? Hematology. 2013;18:360–4.CrossRef
13.
go back to reference Yang SW, Cho SH, Kwon HS, Sohn IS, Hwang HS. Significance of the platelet distribution width as a severity marker for the development of pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2014;175:107–11.CrossRef Yang SW, Cho SH, Kwon HS, Sohn IS, Hwang HS. Significance of the platelet distribution width as a severity marker for the development of pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 2014;175:107–11.CrossRef
14.
go back to reference AlSheeha MA, Alaboudi RS, Alghasham MA, Iqbal J, Adam I. Platelet count and platelet indices in women with pre-eclampsia. Vasc Health Risk Manag. 2016;12:477–80.CrossRef AlSheeha MA, Alaboudi RS, Alghasham MA, Iqbal J, Adam I. Platelet count and platelet indices in women with pre-eclampsia. Vasc Health Risk Manag. 2016;12:477–80.CrossRef
15.
go back to reference Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M. et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected pre-eclampsia. N Engl J Med. 2016;374:13–22.CrossRef Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M. et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected pre-eclampsia. N Engl J Med. 2016;374:13–22.CrossRef
16.
go back to reference Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A. et al. Aspirin versus placebo in pregnancies at high risk for preterm pre-eclampsia. N Engl J Med. 2017;377:613 – 22., de Paco Matallana C.CrossRef Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A. et al. Aspirin versus placebo in pregnancies at high risk for preterm pre-eclampsia. N Engl J Med. 2017;377:613 – 22., de Paco Matallana C.CrossRef
Metadata
Title
Mild thrombocytopenia indicating maternal organ damage in pre‐eclampsia: a cross‐sectional study
Authors
Michinori Mayama
Mamoru Morikawa
Takashi Yamada
Takeshi Umazume
Kiwamu Noshiro
Kinuko Nakagawa
Yoshihiro Saito
Kentaro Chiba
Satoshi Kawaguchi
Hidemichi Watari
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2021
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-021-03564-4

Other articles of this Issue 1/2021

BMC Pregnancy and Childbirth 1/2021 Go to the issue